Annual Long Term Debt
$536.00 K
-$1.30 M-70.84%
31 December 2023
Summary:
Compass Therapeutics annual long term debt is currently $536.00 thousand, with the most recent change of -$1.30 million (-70.84%) on 31 December 2023. During the last 3 years, it has fallen by -$1.33 million (-71.29%). CMPX annual long term debt is now -95.16% below its all-time high of $11.06 million, reached on 01 December 2018.CMPX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$6.32 M
+$6.32 M+100.00%
01 September 2024
Summary:
Compass Therapeutics quarterly long term debt is currently $6.32 million, with the most recent change of +$6.32 million (+100.00%) on 01 September 2024. Over the past year, it has increased by +$5.45 million (+627.27%). CMPX quarterly long term debt is now -31.99% below its all-time high of $9.29 million, reached on 01 December 2019.CMPX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CMPX Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -70.8% | +627.3% |
| 3 y3 years | -71.3% | +89.9% |
| 5 y5 years | -95.2% | - |
CMPX Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -82.4% | at low | at high | |
| 5 y | 5 years | -95.2% | at low | -32.0% | |
| alltime | all time | -95.2% | at low | -32.0% |
Compass Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.32 M(>+9900.0%) |
| June 2024 | - | $0.00(-100.0%) |
| Mar 2024 | - | $189.00 K(-64.7%) |
| Dec 2023 | $536.00 K(-70.8%) | $536.00 K(-38.3%) |
| Sept 2023 | - | $869.00 K(-27.4%) |
| June 2023 | - | $1.20 M(-21.3%) |
| Mar 2023 | - | $1.52 M(-17.3%) |
| Dec 2022 | $1.84 M | $1.84 M(-14.3%) |
| Sept 2022 | - | $2.14 M(-12.3%) |
| June 2022 | - | $2.44 M(-10.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $2.74 M(-10.1%) |
| Dec 2021 | $3.05 M(+63.3%) | - |
| Dec 2021 | - | $3.05 M(-8.4%) |
| Sept 2021 | - | $3.33 M(-7.7%) |
| June 2021 | - | $3.60 M(-7.0%) |
| Mar 2021 | - | $3.88 M(+107.7%) |
| Dec 2020 | $1.87 M(-79.9%) | $1.87 M(-49.9%) |
| Sept 2020 | - | $3.73 M(-33.3%) |
| June 2020 | - | $5.59 M(-39.8%) |
| Dec 2019 | $9.29 M(-16.0%) | $9.29 M |
| Dec 2018 | $11.06 M | - |
FAQ
- What is Compass Therapeutics annual long term debt?
- What is the all time high annual long term debt for Compass Therapeutics?
- What is Compass Therapeutics annual long term debt year-on-year change?
- What is Compass Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Compass Therapeutics?
- What is Compass Therapeutics quarterly long term debt year-on-year change?
What is Compass Therapeutics annual long term debt?
The current annual long term debt of CMPX is $536.00 K
What is the all time high annual long term debt for Compass Therapeutics?
Compass Therapeutics all-time high annual long term debt is $11.06 M
What is Compass Therapeutics annual long term debt year-on-year change?
Over the past year, CMPX annual long term debt has changed by -$1.30 M (-70.84%)
What is Compass Therapeutics quarterly long term debt?
The current quarterly long term debt of CMPX is $6.32 M
What is the all time high quarterly long term debt for Compass Therapeutics?
Compass Therapeutics all-time high quarterly long term debt is $9.29 M
What is Compass Therapeutics quarterly long term debt year-on-year change?
Over the past year, CMPX quarterly long term debt has changed by +$5.45 M (+627.27%)